Hoylecohen, LLC
- SEC CIK
- 0001559077
- Latest filing
- Jul 19, 2024
NVO holding history
Novo Nordisk A S in every 13F filed by Hoylecohen, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVO overviewAll 13F holders of NVOFull Q2 2024 holdings
- Shares (Q2 2024)
- 20,640
- Value
- $2.95M
- % of portfolio
- 0.2%
- Quarters held
- 14
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 20,640 | $2.95M | 0.2% | +643+3.2% | Added | Holders |
| Q1 2024 | 19,997 | $2.57M | 0.2% | +10,777+116.9% | Added | Holders |
| Q4 2023 | 9,220 | $953.8K | 0.1% | +920+11.1% | Added | Holders |
| Q3 2023 | 8,300 | $754.8K | 0.1% | 00.0% | UnchangedConverted for a 2-for-1 split | Holders |
| Q2 2023 | 4,143 | $670.5K | 0.1% | −107−2.5% | Reduced | Holders |
| Q1 2023 | 4,250 | $676.3K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 4,250 | $575.2K | 0.1% | −15−0.4% | Reduced | Holders |
| Q3 2022 | 4,265 | $425.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 4,265 | $475.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 4,265 | $474.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 4,265 | $478.0K | <0.1% | +50+1.2% | Added | Holders |
| Q3 2021 | 4,215 | $405.0K | <0.1% | −75−1.7% | Reduced | Holders |
| Q2 2021 | 4,290 | $359.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 4,290 | $289.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.